Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells - PubMed (original) (raw)
. 1990 Jul 15;265(20):11487-94.
Affiliations
- PMID: 2142153
Free article
Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells
N G Ahn et al. J Biol Chem. 1990.
Free article
Abstract
Growth factor activation of serine/threonine protein kinases was studied by treating quiescent Swiss 3T3 cells with epidermal growth factor (EGF) and examining cytosolic extracts for protein kinase activity under conditions inhibitory to calcium- and cyclic nucleotide-dependent kinases. Cytosolic extracts of cells stimulated for 5 min were fractionated by Mono Q fast protein liquid chromatography. Eight peaks of kinase activity were resolved, of which five were stimulated by EGF treatment of cells. These peaks were revealed using the synthetic peptide Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala (S6 peptide), 40 S ribosomal S6 protein, glycogen synthase, microtubule-associated protein 2, and myelin basic protein as substrates. The peaks varied in the kinetics of their activation by EGF and in their response to insulin. Selected peaks were resolved further by sizing gel chromatography. The results together indicate that at least seven distinct fractions of cytosolic kinase activities are stimulated in Swiss 3T3 cells by EGF. One of these, which phosphorylates both S6 protein and S6 peptide, is similar to the S6 kinase characterized previously in this cell line by others. Four additional activities that also phosphorylate the S6 protein and S6 peptide appear unrelated to this enzyme. Finally, two kinase activities that phosphorylate both myelin basic protein and microtubule associated protein 2 are EGF stimulated. One is similar to an insulin-stimulated microtubule-associated protein 2 kinase described in other cell lines whereas the other seems to represent a novel activity. Several of these EGF-stimulated activities were inactivated by protein phosphatases, suggesting that they might be regulated by phosphorylation.
Similar articles
- Rapid stimulation of Ser/Thr protein kinases following treatment of Swiss 3T3 cells with bombesin. Involvement of casein kinase-2 in the signaling pathway of bombesin.
Agostinis P, Van Lint J, Sarno S, De Witte P, Vandenheede JR, Merlevede W. Agostinis P, et al. J Biol Chem. 1992 May 15;267(14):9732-7. J Biol Chem. 1992. PMID: 1577810 - Activation of a serine/threonine kinase that phosphorylates microtubule-associated protein 1B in vitro by growth factors and phorbol esters in quiescent rat fibroblastic cells.
Hoshi M, Nishida E, Inagaki M, Gotoh Y, Sakai H. Hoshi M, et al. Eur J Biochem. 1990 Oct 24;193(2):513-9. doi: 10.1111/j.1432-1033.1990.tb19366.x. Eur J Biochem. 1990. PMID: 2226468 - Purification and characterization of a cytosolic insulin-stimulated serine kinase from rat liver.
Wolfe L, Bradford AP, Klarlund JK, Czech MP. Wolfe L, et al. J Biol Chem. 1992 May 15;267(14):9749-56. J Biol Chem. 1992. PMID: 1533638 - Sequential activation of MAP kinase activator, MAP kinases, and S6 peptide kinase in intact rat liver following insulin injection.
Tobe K, Kadowaki T, Hara K, Gotoh Y, Kosako H, Matsuda S, Tamemoto H, Ueki K, Akanuma Y, Nishida E, et al. Tobe K, et al. J Biol Chem. 1992 Oct 15;267(29):21089-97. J Biol Chem. 1992. PMID: 1328222
Cited by
- An in silico molecular docking and simulation study to identify potential anticancer phytochemicals targeting the RAS signaling pathway.
Azmal M, Paul JK, Prima FS, Talukder OF, Ghosh A. Azmal M, et al. PLoS One. 2024 Sep 19;19(9):e0310637. doi: 10.1371/journal.pone.0310637. eCollection 2024. PLoS One. 2024. PMID: 39298437 Free PMC article. - Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.
Bahar ME, Kim HJ, Kim DR. Bahar ME, et al. Signal Transduct Target Ther. 2023 Dec 18;8(1):455. doi: 10.1038/s41392-023-01705-z. Signal Transduct Target Ther. 2023. PMID: 38105263 Free PMC article. Review. - Drug resistance in targeted cancer therapies with RAF inhibitors.
Degirmenci U, Yap J, Sim YRM, Qin S, Hu J. Degirmenci U, et al. Cancer Drug Resist. 2021 Jun 17;4(3):665-683. doi: 10.20517/cdr.2021.36. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582307 Free PMC article. Review. - Isoform-specific roles for AKT in affective behavior, spatial memory, and extinction related to psychiatric disorders.
Wong H, Levenga J, LaPlante L, Keller B, Cooper-Sansone A, Borski C, Milstead R, Ehringer M, Hoeffer C. Wong H, et al. Elife. 2020 Dec 16;9:e56630. doi: 10.7554/eLife.56630. Elife. 2020. PMID: 33325370 Free PMC article. - The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.
Yuan J, Dong X, Yap J, Hu J. Yuan J, et al. J Hematol Oncol. 2020 Aug 17;13(1):113. doi: 10.1186/s13045-020-00949-4. J Hematol Oncol. 2020. PMID: 32807225 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources